Latest drugs in limited distribution, indicated for patients with pericarditis and rare lung cancers, now available in specialized pharmacy
ORLANDO, Florida, September 28, 2021 / PRNewswire / – Drugs prescribed for the treatment of specific types of cancer as well as autoinflammatory cardiovascular disease are now available through AllianceRx Walgreens Prime.
Arcalyst® (rilonacept) is the first and only product approved by the FDA for the treatment of recurrent pericarditis and the reduction of the risk of recurrence. Pericarditis is a painful and debilitating autoinflammatory cardiovascular disease associated with swelling of the sac-like membrane surrounding the heart. Arcalyst is also approved by the FDA for the treatment of cryopyrin-associated periodic syndromes (CAPS), a group of rare inherited autoinflammatory disorders, including familial cold autoinflammatory syndrome and Muckle-Wells syndrome, and for maintenance of remission of interleukin deficiency. 1 Receptor antagonist (DIRA), an autoinflammatory disease affecting less than 50 people worldwide. Kiniksa Pharmaceuticals manufactures Arcalyst, which is also a registered trademark of Regeneron Pharmaceuticals, Inc.
Gavreto® (pralsetinib) is a once-daily prescription oral medication used to treat certain cancers caused by RET-positive (rearranged during transfection) genes in non-small cell lung cancer that has spread (metastatic) or advanced thyroid cancer that may have spread. Blueprint Medicines manufactures Gavreto.
“Patients living with these rare autoinflammatory diseases and cancers deserve to have access to the best treatment options available to help them manage these conditions,” says Tracey James, Senior Vice President of Pharmaceutical Services. “We are delighted that these manufacturers have chosen AllianceRx Walgreens Prime to dispense these drugs. Our specialist pharmacists engage and advise patients on prescribed treatment and help improve adherence and persistence. Manufacturers partner with us because of our continued commitment to providing patients with the individualized support and clinical expertise necessary to improve patient outcomes.
For full prescribing information and warnings for any of these drugs, visit the manufacturers’ websites or dailymed.nlm.nih.gov.
About AllianceRx Walgreens Prime
AllianceRx Walgreens Prime (alliancerxwp.com) is a specialty and home delivery pharmacy that strives to provide exceptional care throughout a patient’s treatment journey with the medications they need every day. Formed in 2017 through a collaboration between Walgreens, one of the nation’s largest drugstore chains, and Prime Therapeutics, a leading pharmacy benefit manager, the company provides tools and resources for patients, providers and health plans to achieve optimal health outcomes. The company is headquartered in Orlando, Florida and its pharmacies are accredited by several national pharmacies accreditation services.
Adrienne foley, APR
External communications manager
View original content to download multimedia: https://www.prnewswire.com/news-releases/life-changing-medicines-arcalyst-and-gavreto-now-available-at-alliancerx-walgreens-prime-301386571.html
SOURCE AllianceRx Walgreens Prime